2,100 sarcoma survivors join landmark study to uncover hidden Long-Term effects

This study follows 2,100 people of all ages who have had sarcoma, a rare cancer, to learn how the disease and its treatments affect them over time. Participants will fill out surveys, give blood, saliva, urine, stool, and tissue samples, and wear a FitBit to track activity. The goal is to better understand the long-term physical and emotional challenges survivors face, which could help improve future care and support.